Wellington Management Group
AXDX

Wellington Management Group’s Accelerate Diagnostics AXDX Stock Holding History

Wellington Management Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,312
Closed -$1.14M – 2167
2014
Q3 		$1.14M Buy
+5,312
New +$1.03M ﹤0.01% 1800

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group's AXDX Position: Q4 2014 in Review

Wellington Management Group sold out of Accelerate Diagnostics (AXDX) in Q4 2014, closing a stake of 5,312 shares — an estimated $1.14M sold.

Wellington Management Group first reported a position in AXDX in Q3 2014 and held it in 1 quarter. The position peaked at $1.14M in Q3 2014. 78 funds tracked by Wall St. Rank hold AXDX as of Q4 2014.

  • Wellington Management Group reported no remaining Accelerate Diagnostics position as of Q4 2014 after selling out during the quarter.
  • Wellington Management Group sold 5,312 Accelerate Diagnostics shares in Q4 2014, an estimated $1.14M.
  • Wellington Management Group first reported a position in Accelerate Diagnostics in Q3 2014 and held it in 1 quarter.
  • Wellington Management Group's Accelerate Diagnostics position peaked at $1.14M in Q3 2014.
  • 78 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2014.

Based on Wellington Management Group's 13F filing for Q4 2014, filed 13 Feb 2015.